1. Saeedi, P, Petersohn, I, Salpea, P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9. Diabetes Res Clin Pract. Nov 2019;157:107843. doi:10.1016/j.diabres.2019.107843
Google Scholar | Crossref | Medline2. Boulton, AJ, Vileikyte, L, Ragnarson-Tennvall, G, Apelqvist, J. The global burden of diabetic foot disease. Lancet. Nov 2005;366(9498):1719-24. doi:10.1016/S0140-6736(05)67698-2
Google Scholar | Crossref | Medline3. Lazzarini, PA, Pacella, RE, Armstrong, DG, van Netten, JJ. Diabetes-related lower-extremity complications are a leading cause of the global burden of disability. Diabet Med. May 2018;doi:10.1111/dme.13680
Google Scholar | Crossref | Medline4. van Netten, JJ, Bus, SA, Apelqvist, J, et al. Definitions and criteria for diabetic foot disease. Diabetes Metab Res Rev. 03 2020;36 Suppl 1:e3268. doi:10.1002/dmrr.3268
Google Scholar | Crossref | Medline5. Armstrong, DG, Boulton, AJM, Bus, SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 06 2017;376(24):2367-2375. doi:10.1056/NEJMra1615439
Google Scholar | Crossref | Medline | ISI6. Bobircă, F, Mihalache, O, Georgescu, D, Pătraşcu, T. The New Prognostic-Therapeutic Index for Diabetic Foot Surgery–Extended Analysis. Chirurgia (Bucur). 2016 Mar-Apr 2016;111(2):151-5.
Google Scholar | Medline7. Moxey, PW, Gogalniceanu, P, Hinchliffe, RJ, et al. Lower extremity amputations–a review of global variability in incidence. Diabet Med. Oct 2011;28(10):1144-53. doi:10.1111/j.1464-5491.2011.03279.x
Google Scholar | Crossref | Medline | ISI8. Gatev, T, Gateva, A, Assyov, Y, et al. The role of Sudoscan feet asymmetry in the diabetic foot. Prim Care Diabetes. May 2019;doi:10.1016/j.pcd.2019.05.003
Google Scholar | Crossref | Medline9. Unwin, N . Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia. Br J Surg. 03 2000;87(3):328-37. doi:10.1046/j.1365-2168.2000.01344.x
Google Scholar | Crossref | Medline | ISI10. Armstrong, DG, Lavery, LA, van Houtum, WH, Harkless, LB. The impact of gender on amputation. J Foot Ankle Surg. 1997 Jan-Feb 1997;36(1):66-9; discussion 81.
Google Scholar | Crossref | Medline11. Most, RS, Sinnock, P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care. 1983 Jan-Feb 1983;6(1):87-91.
Google Scholar | Crossref | Medline | ISI12. Resnick, HE, Carter, EA, Sosenko, JM, et al. Incidence of lower-extremity amputation in American Indians: the Strong Heart Study. Diabetes Care. Aug 2004;27(8):1885-91.
Google Scholar | Crossref | Medline13. Apelqvist, J, Larsson, J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev. 2000 Sep-Oct 2000;16 Suppl 1:S75-83. doi:10.1002/1520-7560(200009/10)16:1+<::aid-dmrr139 > 3.0.co;2-8
Google Scholar | Crossref | Medline14. Coelho, M, Oliveira, T, Fernandes, R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. Apr 2013;9(2):191-200. doi:10.5114/aoms.2013.33181
Google Scholar | Crossref | Medline15. Fantuzzi, G, Mazzone, T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol. May 2007;27(5):996-1003. doi:10.1161/ATVBAHA.106.131755
Google Scholar | Crossref | Medline16. Matsuda, M, Shimomura, I, Sata, M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem. Oct 2002;277(40):37487-91. doi:10.1074/jbc.M206083200
Google Scholar | Crossref | Medline17. Tuttolomondo, A, Maida, C, Pinto, A. Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients. J Diabetes Res. 2015;2015:268390. doi:10.1155/2015/268390
Google Scholar | Crossref | Medline18. Schäffler, A, Neumeier, M, Herfarth, H, Fürst, A, Schölmerich, J, Büchler, C. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta. Dec 2005;1732(1-3):96-102. doi:10.1016/j.bbaexp.2005.11.005
Google Scholar | Crossref | Medline19. Yang, RZ, Lee, MJ, Hu, H, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab. Jun 2006;290(6):E1253-61. doi:10.1152/ajpendo.00572.2004
Google Scholar | Crossref | Medline | ISI20. Batista CM, de Souza, Yang, RZ, Lee, MJ, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. Jun 2007;56(6):1655-61. doi:10.2337/db06-1506
Google Scholar | Crossref | Medline21. Yamawaki, H, Tsubaki, N, Mukohda, M, Okada, M, Hara, Y. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun. Mar 2010;393(4):668-72. doi:10.1016/j.bbrc.2010.02.053
Google Scholar | Crossref | Medline | ISI22. Yamawaki, H, Kuramoto, J, Kameshima, S, Usui, T, Okada, M, Hara, Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun. May 2011;408(2):339-43. doi:10.1016/j.bbrc.2011.04.039
Google Scholar | Crossref | Medline | ISI23. Biscetti, F, Nardella, E, Bonadia, N, et al. Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease. Cardiovasc Diabetol. 06 2019;18(1):74. doi:10.1186/s12933-019-0880-7
Google Scholar | Crossref | Medline24. Shibata, R, Ouchi, N, Kikuchi, R, et al. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis. Dec 2011;219(2):811-4. doi:10.1016/j.atherosclerosis.2011.08.017
Google Scholar | Crossref | Medline | ISI25. Narumi, T, Watanabe, T, Kadowaki, S, et al. Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure. Cardiovasc Diabetol. Apr 2014;13:84. doi:10.1186/1475-2840-13-84
Google Scholar | Crossref | Medline26. Yoo, HJ, Hwang, SY, Hong, HC, et al. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol. Nov 2011;10:103. doi:10.1186/1475-2840-10-103
Google Scholar | Crossref | Medline27. Matsuo, K, Shibata, R, Ohashi, K, et al. Omentin functions to attenuate cardiac hypertrophic response. J Mol Cell Cardiol. Feb 2015;79:195-202. doi:10.1016/j.yjmcc.2014.11.019
Google Scholar | Crossref | Medline28. Pan, HY, Guo, L, Li, Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract. Apr 2010;88(1):29-33. doi:10.1016/j.diabres.2010.01.013
Google Scholar | Crossref | Medline | ISI29. Herder, C, Ouwens, DM, Carstensen, M, et al. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study. Eur J Endocrinol. Apr 2015;172(4):423-32. doi:10.1530/EJE-14-0879
Google Scholar | Crossref | Medline30. Cavanagh, P, Attinger, C, Abbas, Z, Bal, A, Rojas, N, Xu, ZR. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev. Feb 2012;28 Suppl 1:107-11. doi:10.1002/dmrr.2245
Google Scholar | Crossref | Medline31. Zorena, K, Jachimowicz-Duda, O, Ślęzak, D, Robakowska, M, Mrugacz, M. Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications. Int J Mol Sci. May 2020;21(10)doi:10.3390/ijms21103570
Google Scholar | Crossref | Medline32. Liang, W, Ye, DD. The potential of adipokines as biomarkers and therapeutic agents for vascular complications in type 2 diabetes mellitus. Cytokine Growth Factor Rev. 08 2019;48:32-39. doi:10.1016/j.cytogfr.2019.06.002
Google Scholar | Crossref | Medline33. Wannamethee, SG, Lowe, GD, Rumley, A, Cherry, L, Whincup, PH, Sattar, N. Adipokines and risk of type 2 diabetes in older men. Diabetes Care. May 2007;30(5):1200-5. doi:10.2337/dc06-2416
Google Scholar | Crossref | Medline34. Tuttolomondo, A, Maida, C, Pinto, A. Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes. World J Orthop. Jan 2015;6(1):62-76. doi:10.5312/wjo.v6.i1.62
Google Scholar | Crossref | Medline35. Tuttolomondo, A, La Placa, S, Di Raimondo, D, et al. Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol. Sep 2010;9:50. doi:10.1186/1475-2840-9-50
Google Scholar | Crossref | Medline36. Zubair, M, Malik, A, Ahmad, J. Plasma adiponectin, IL-6, hsCRP, and TNF-α levels in subject with diabetic foot and their correlation with clinical variables in a North Indian tertiary care hospital. Indian J Endocrinol Metab. Sep 2012;16(5):769-76. doi:10.4103/2230-8210.100672
Google Scholar | Crossref | Medline37. Pan, X, Kaminga, AC, Wen, SW, Acheampong, K, Liu, A. Omentin-1 in diabetes mellitus: A systematic review and meta-analysis. PLoS One. 2019;14(12):e0226292. doi:10.1371/journal.pone.0226292
Google Scholar | Crossref | Medline38. Herder, C, Bongaerts, BW, Ouwens, DM, et al. Low serum omentin levels in the elderly population with Type 2 diabetes and polyneuropathy. Diabet Med. Nov 2015;32(11):1479-83. doi:10.1111/dme.12761
Google Scholar | Crossref | Medline39. Niersmann, C, Carstensen-Kirberg, M, Maalmi, H, et al. Higher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes. Diabetologia. 02 2020;63(2):410-418. doi:10.1007/s00125-019-05017-2
Google Scholar | Crossref | Medline40. Dinh, T, Tecilazich, F, Kafanas, A, et al. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. Nov 2012;61(11):2937-47. doi:10.2337/db12-0227
Google Scholar | Crossref | Medline41. Tsui, EY, Gao, XJ, Zinman, B. Bioelectrical impedance analysis (BIA) using bipolar foot electrodes in the assessment of body composition in Type 2 diabetes mellitus. Diabet Med. Feb 1998;15(2):125-8. doi:10.1002/(SICI)1096-9136(199802)15:2 < 125::AID-DIA532 > 3.0.CO;2-N
Google Scholar | Crossref | Medline42. Beeson, WL, Batech, M, Schultz, E, et al. Comparison of body composition by bioelectrical impedance analysis and dual-energy X-ray absorptiometry in Hispanic diabetics. Int J Body Compos Res. 2010;8(2):45-50.
Google Scholar | Medline43. Coppini, LZ, Waitzberg, DL, Campos, AC. Limitations and validation of bioelectrical impedance analysis in morbidly obese patients. Curr Opin Clin Nutr Metab Care. May 2005;8(3):329-32. doi:10.1097/01.mco.0000165013.54696.64
Google Scholar | Crossref | Medline44. Lin, CW, Hsu, BR, Tsai, JS, et al. Effect of limb preservation status and body mass index on the survival of patients with limb-threatening diabetic foot ulcers. J Diabetes Complications. 01 2017;31(1):180-185. doi: